human Platelet Lysate Tag

A new publication from Kouroupis et al. published in CYTOTHERAPY in July 2020 found out that infrapatellar fat pad (IFP)-mesenchymal stem cells (MSCs) manufactured with human Platelet Lysate (hPL) show enhanced immunomodulatory properties. Findings have potential for a minimally invasive cell therapy for joint disease The authors even

READ MORE
Any questions?
close slider

Any questions?

Please contact us:

support@pl-bioscience.com

+49 (0) 241 95719-100